ATPC (Agape ATP Corp) Market Value to Book Value Ratio

Official company branding of agapeatpgroup.com (ATPC)

The market price of Agape ATP Corporation (ATPC), as confirmed by the chart, reflects the dynamics of a business focused on Southeast Asian residents purchasing dietary supplements and wellness services for metabolic correction. Agape ATP Corporation (ATPC) is developing digital metabolic health systems and retaining customers through express diagnostics, with the current metric standing at 0.07. However, sales growth is limited by high regional promotion costs, which are constraining operational efficiency.

ATPC agapeatpgroup.com: Market Value to Book Value in the range 02/21/2024 - 10/28/2026

Financial and market metric breakdowns for Agape ATP Corporation (ATPC)

- price and consensus price forecast:
Stock Price agapeatpgroup.com|ATPC - Consensus Target
- market capitalization data:
Market Value Agape ATP Corp.|ATPC - Full Business Value
- book capitalization data:
Book Value per Share Agape ATP|ATPC - Accounting Value of Company|Market Capitalization to Book Value Ratio agapeatpgroup.com|ATPC - Company Total Assets
- debt and liquidity data:
Debt to Equity Agape ATP Corporation|ATPC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity agapeatpgroup.com|ATPC - Company Total Debt|Debts to Book Capitalization Agape ATP Corp.|ATPC - Company Long-Term Debts|Company Current Liabilities Agape ATP
Initial company analysis:Agape ATP Corp - ATPC
Original product of agapeatpgroup.com

Investors seek a balance between the intrinsic value of a business and market expectations. This ratio compares current market capitalization with net assets, revealing the extent of the company's overvaluation or discount. For Agape ATP Corporation (ATPC), this metric reflects the value of its strategic alliances in Malaysia and its medical software. By analyzing the price-to-book ratio, one can determine the investment's margin of safety.

Main competitors

ASND (Ascendis Pharma A/S) - Market Capitalization to Book Value Ratio|MDGL (madrigalpharma.com) - Market Cap to Net Assets Ratio|Market Value to Book Value Ratio Corcept Therapeutics Incorporated CORT|Market Capitalization to Net Assets Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Market Capitalization to Book Value Ratio|Market Value to Book Value Metsera Therapeutics (MTSR)|Market Capitalization to Book Value Ratio MLTX (MoonLake Immunotherapeutics)|crinetics.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Market Value to Book Value|FOLD (Amicus Pharma) - Market Value to Book Value Ratio|89bio Pharma (ETNB) - Market Cap to Net Assets Ratio|AGIO (Agios Pharmaceuticals) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio structuretx.com (GPCR)|MiMedx (MDXG) - Market Cap to Net Assets Ratio|Market Value to Book Value RZLT (Rezolute Inc)|Lexicon Pharma - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio MBX Corp MBX|ALT (Altimmune, Inc.) - Market Capitalization to Book Value Ratio|aardvarktherapeutics.com (AARD) - Market-to-Book Ratio|SGMT - Market Cap to Net Assets Ratio|BioAge Labs (BIOA) - Market Cap to Book Value Multiple|BMEA (Biomea) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Quince|Market Capitalization to Book Value Ratio Fractyl Health, Inc. (GUTS)|Market Value to Book Value Ratio VTVT (vtvtherapeutics.com)|PLUR: Market Value to Book Value Ratio|Synlogic Inc. - Market-to-Book Ratio|LPCN - Market Value to Book Value Ratio|MTNB - Market Value to Book Value Ratio|Spruce Biosciences - Market Capitalization to Book Value Ratio|GLTO (galecto.com) - Market Capitalization to Book Value|CTCX: Market Value to Book Value Ratio|Market Capitalization to Book Value LUMO|Market Value to Book Value Ratio ONVO (Organovo Holdings Inc)|Market Cap to Net Assets Ratio Radius Pharmaceuticals (RDUS)